Patent ID: 7465450

Claim:
A method for treating septic arthritis, comprising administering an anti-IL4 receptor antibody to a mammal afflicted with septic arthritis, wherein said antibody is selected from the group of antibodies consisting of: a) An anti-IL4 receptor antibody, wherein the light chain of said antibody comprises the CDR 1 sequence of residues 24-35 of SEQ ID NO:10, the CDR 2 sequence of residues 51-57 of SEQ ID NO:10, and the CDR 3 sequence of residues 90-99 of SEQ ID NO:10 and the heavy chain of said antibody comprises the CDR 1 sequence of residues 31-35 of SEQ ID NO:12, the CDR 2 sequence of residues of residues 50-65 of SEQ ID NO:12, and the CDR 3 sequence of residues 98-104 of SEQ ID NO:12, b) An anti-IL4 receptor antibody, wherein the light chain of said antibody comprises the variable domain of SEQ ID NO:10, and c) An anti-IL4 receptor antibody, wherein the heavy chain of said antibody comprises the variable domain of SEQ ID NO:12.